Lung Cancer

The FDA approved cemiplimab-rwlc in combination with platinum-based chemotherapy for first-line treatment of advanced non-small cell lung cancer.

Significant action is necessary to prioritize early detection of lung cancer through expanded screening for high-risk individuals, according to a consensus statement released today.

NASHVILLE, Tenn. — In this Healio exclusive, Jaspal Singh, MD, FCCP, discusses trends and advancements coming out of the CHEST Annual Meeting.

NASHVILLE, Tenn. — Lung cancer survivors had similar or increased frequency of and risk for cardiovascular comorbidities and substance abuse than patients with active lung cancer, according to a presenter at the CHEST Annual Meeting.

GENEVA — Lower BMI may increase risk for lung cancer, according to results of an ongoing prospective study presented at World Cancer Congress.

NASHVILLE, Tenn. — In this Healio exclusive, Jaspal Singh, MD, FCCP, provides his takeaways from the CHEST Annual Meeting.

From 2015 to 2019, most patients who were screened for lung cancer met 2013 U.S. Preventive Services Task Force criteria, but men, younger patients and those who previously smoked were less likely to be screened, a recent study found.

NASHVILLE, Tenn. — Shape-sensing robotic-assisted bronchoscopy with cone-beam CT imaging showed promise for diagnosing central, distal-airway and peripheral pulmonary lesions in a single-center study presented at the CHEST Annual Meeting.

The presence of non-cystic fibrosis bronchiectasis increased risk for lung cancer regardless of smoking status, according to recent findings published in Annals of the American Thoracic Society.

Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology researchers.